Gene · 6300
Papers1,954
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,954
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in molecular targeted therapies to increase efficacy of (chemo)radiation therapy. | Strahlenther Onkol | 2023 | 37041372 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| ERK Inhibition Promotes Engraftment of Allografts by Reprogramming T-Cell Metabolism. | Adv Sci (Weinh) | 2023 | 37013935 | PubTator, text mining | PubMed |
| Expression patterns of eight RNA-modified regulators correlating with immune infiltrates during the progression of osteoarthritis. | Front Immunol | 2023 | 37006267 | PubTator, text mining | PubMed |
| CoNet: Efficient Network Regression for Survival Analysis in Transcriptome-Wide Association Studies-With Applications to Studies of Breast Cancer. | Genes (Basel) | 2023 | 36980857 | PubTator, text mining | PubMed |
| Computational and Functional Analysis of Structural Features in the ZAKα Kinase. | Cells | 2023 | 36980309 | PubTator, text mining | PubMed |
| MPK12 in stomatal CO2 signaling: function beyond its kinase activity. | New Phytol | 2023 | 36978283 | PubTator, text mining | PubMed |
| Plasma proteomics of SARS-CoV-2 infection and severity reveals impact on Alzheimer's and coronary disease pathways. | iScience | 2023 | 36974157 | PubTator, text mining | PubMed |
| Chemical Knockdown of Phosphorylated p38 Mitogen-Activated Protein Kinase (MAPK) as a Novel Approach for the Treatment of Alzheimer's Disease. | ACS Cent Sci | 2023 | 36968534 | PubTator, text mining | PubMed |
| Immunoregulatory actions of calf thymus extract (TFX®) in vitro in relation to its effect on expression of mitogen activated protein kinases. | Int Immunopharmacol | 2023 | 36963263 | PubTator, text mining | PubMed |
| Topoisomerase I poisons-induced autophagy: Cytoprotective, Cytotoxic or Non-protective. | Autophagy Rep | 2023 | 36936397 | PubTator, text mining | PubMed |
| Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 mice. | EBioMedicine | 2023 | 36933413 | PubTator, text mining | PubMed |
| Identification of a novel senescence-associated signature to predict biochemical recurrence and immune microenvironment for prostate cancer. | Front Immunol | 2023 | 36891298 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of the Inflammation-Associated lncRNA-mRNA Coexpression Network in Type 2 Diabetes. | J Renin Angiotensin Aldosterone Syst | 2023 | 36874406 | PubTator, text mining | PubMed |
| Identification of novel miRNAs potentially involved in the pathogenesis of adult T-cell leukemia/lymphoma using WGCNA followed by RT-qPCR test of hub genes. | Infect Agent Cancer | 2023 | 36841815 | PubTator, text mining | PubMed |
| Luteoloside Induces G0/G1 Phase Arrest of Neuroblastoma Cells by Targeting p38 MAPK. | Molecules | 2023 | 36838737 | PubTator, text mining | PubMed |
| MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges. | Cells | 2023 | 36831285 | PubTator, text mining | PubMed |
| Cellular and Molecular Control of Lipid Metabolism in Idiopathic Pulmonary Fibrosis: Clinical Application of the Lysophosphatidic Acid Pathway. | Cells | 2023 | 36831215 | PubTator, text mining | PubMed |
| Liaisons dangereuses: Intrinsic Disorder in Cellular Proteins Recruited to Viral Infection-Related Biocondensates. | Int J Mol Sci | 2023 | 36768473 | PubTator, text mining | PubMed |
| The Dynamic and Crucial Role of the Arginine Methylproteome in Myoblast Cell Differentiation. | Int J Mol Sci | 2023 | 36768448 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6300/papers?page=11